Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Blanchette

Showing results (91-100 of 200) with videos related to

Pageof 20
Sort By:
Journal of Pediatric Hematology/Oncology|February 7, 2003
Self-reported initial management of childhood idiopathic thrombocytopenic purpura: results of a survey of members of the American Society of Pediatric Hematology/Oncology, 2001Sara K Vesely, George R Buchanan, Leah Adix, et al.
Journal of Thrombosis and Haemostasis : JTH|July 23, 2003
Intensive exposure to factor VIII is a risk factor for inhibitor development in mild hemophilia AA Sharathkumar, D Lillicrap, V S Blanchette, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|January 18, 2006
Canadian multi-institutional survey of immune tolerance therapy (ITT) -- experience with the use of recombinant factor VIII for ITTC Barnes, G E Rivard, M-C Poon, et al.
Journal of Thrombosis and Haemostasis : JTH|April 22, 2004
Triple heterozygosity in the integrin alphaIIb subunit in a patient with Glanzmann's thrombastheniaA T Nurden, C Breillat, B Jacquelin, et al.
Pediatric Blood & Cancer|December 8, 2005
The prevention and treatment of bacterial infections in children with asplenia or hyposplenia: practice considerations at the Hospital for Sick Children, TorontoVictoria E Price, Sanjeev Dutta, Victor S Blanchette, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|December 23, 2019
Measuring the impact of changing from standard half-life (SHL) to extended half-life (EHL) FVIII prophylaxis on health-related quality of life (HRQoL) in boys with moderate/severe haemophilia A: Lessons learned with the CHO-KLAT toolManuel Carcao, Laura Zunino, Nancy L Young, et al.
Transfusion|September 1, 1984
Intensive plasma exchange therapy in ten patients with idiopathic thrombocytopenic purpuraV S Blanchette, V A Hogan, N E McCombie, et al.
American Journal of Hematology|July 27, 2010
Phosphatidylserine exposure and other apoptotic-like events in Bernard-Soulier syndrome plateletsMargaret L Rand, Hong Wang, K W Annie Bang, et al.
Research and Practice in Thrombosis and Haemostasis|October 3, 2022
Thromboelastography and thrombin generation assessments for pediatric severe hemophilia A patients are highly variable and not predictive of clinical phenotypesNatalie Mathews, Fred G Pluthero, Margaret L Rand, et al.
Pediatric Blood & Cancer|February 5, 2011
Platelet disorders in children: A diagnostic approachSara J Israels, Walter H A Kahr, Victor S Blanchette, et al.
Pageof 20

Showing results (91-100 of 200) with videos related to

Sort By:
Pageof 20
Journal of Pediatric Hematology/Oncology|February 7, 2003
Self-reported initial management of childhood idiopathic thrombocytopenic purpura: results of a survey of members of the American Society of Pediatric Hematology/Oncology, 2001Sara K Vesely, George R Buchanan, Leah Adix, et al.
Journal of Thrombosis and Haemostasis : JTH|July 23, 2003
Intensive exposure to factor VIII is a risk factor for inhibitor development in mild hemophilia AA Sharathkumar, D Lillicrap, V S Blanchette, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|January 18, 2006
Canadian multi-institutional survey of immune tolerance therapy (ITT) -- experience with the use of recombinant factor VIII for ITTC Barnes, G E Rivard, M-C Poon, et al.
Journal of Thrombosis and Haemostasis : JTH|April 22, 2004
Triple heterozygosity in the integrin alphaIIb subunit in a patient with Glanzmann's thrombastheniaA T Nurden, C Breillat, B Jacquelin, et al.
Pediatric Blood & Cancer|December 8, 2005
The prevention and treatment of bacterial infections in children with asplenia or hyposplenia: practice considerations at the Hospital for Sick Children, TorontoVictoria E Price, Sanjeev Dutta, Victor S Blanchette, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|December 23, 2019
Measuring the impact of changing from standard half-life (SHL) to extended half-life (EHL) FVIII prophylaxis on health-related quality of life (HRQoL) in boys with moderate/severe haemophilia A: Lessons learned with the CHO-KLAT toolManuel Carcao, Laura Zunino, Nancy L Young, et al.
Transfusion|September 1, 1984
Intensive plasma exchange therapy in ten patients with idiopathic thrombocytopenic purpuraV S Blanchette, V A Hogan, N E McCombie, et al.
American Journal of Hematology|July 27, 2010
Phosphatidylserine exposure and other apoptotic-like events in Bernard-Soulier syndrome plateletsMargaret L Rand, Hong Wang, K W Annie Bang, et al.
Research and Practice in Thrombosis and Haemostasis|October 3, 2022
Thromboelastography and thrombin generation assessments for pediatric severe hemophilia A patients are highly variable and not predictive of clinical phenotypesNatalie Mathews, Fred G Pluthero, Margaret L Rand, et al.
Pediatric Blood & Cancer|February 5, 2011
Platelet disorders in children: A diagnostic approachSara J Israels, Walter H A Kahr, Victor S Blanchette, et al.
Pageof 20